Furthermore, lentiviral RNAi targeting of ADAM17 down-regulated LPS-induced MMP9 expression via inhibition of TNF-α/NF-κB signaling, which provides a potential target for therapeutic intervention in COPD. This evidence concerns the gene ADAM17 and chronic obstructive pulmonary disease.